Olaparib combined with abiraterone versus olaparib alone for patients with DNA-repair deficient metastatic castration-resistant prostate cancer after progressing on abiraterone: A multicenter, ...
SCPC (1720) has delivered a -1.96% change over the past year, with a 52-week range between 51.20 and 64.90. What Is the Average Daily Trading Volume of SCPC (1720)? The average daily trading volume ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results